210 related articles for article (PubMed ID: 28919038)
21. Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression.
Liu CY; Huang TT; Chen YT; Chen JL; Chu PY; Huang CT; Wang WL; Lau KY; Dai MS; Shiau CW; Tseng LM
EBioMedicine; 2019 Feb; 40():263-275. PubMed ID: 30651219
[TBL] [Abstract][Full Text] [Related]
22. Different effects of 4β-hydroxywithanolide E and withaferin A, two withanolides from Solanaceae plants, on the Akt signaling pathway in human breast cancer cells.
Wang HC; Hu HH; Chang FR; Tsai JY; Kuo CY; Wu YC; Wu CC
Phytomedicine; 2019 Feb; 53():213-222. PubMed ID: 30668401
[TBL] [Abstract][Full Text] [Related]
23. Multiplexed Thiol Reactivity Profiling for Target Discovery of Electrophilic Natural Products.
Tian C; Sun R; Liu K; Fu L; Liu X; Zhou W; Yang Y; Yang J
Cell Chem Biol; 2017 Nov; 24(11):1416-1427.e5. PubMed ID: 28988947
[TBL] [Abstract][Full Text] [Related]
24. Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation.
Kim KY; Baek A; Hwang JE; Choi YA; Jeong J; Lee MS; Cho DH; Lim JS; Kim KI; Yang Y
Cancer Res; 2009 May; 69(9):4018-26. PubMed ID: 19366811
[TBL] [Abstract][Full Text] [Related]
25. Silencing of the PP2A catalytic subunit causes HER-2/neu positive breast cancer cells to undergo apoptosis.
Wong LL; Zhang D; Chang CF; Koay ES
Exp Cell Res; 2010 Dec; 316(20):3387-96. PubMed ID: 20558158
[TBL] [Abstract][Full Text] [Related]
26. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
27. Effect of Withaferin A on A549 cellular proliferation and apoptosis in non-small cell lung cancer.
Cai Y; Sheng ZY; Chen Y; Bai C
Asian Pac J Cancer Prev; 2014; 15(4):1711-4. PubMed ID: 24641396
[TBL] [Abstract][Full Text] [Related]
28. Polyphyllin I inhibits growth and invasion of cisplatin-resistant gastric cancer cells by partially inhibiting CIP2A/PP2A/Akt signaling axis.
Zhang Y; Huang P; Liu X; Xiang Y; Zhang T; Wu Y; Xu J; Sun Z; Zhen W; Zhang L; Si Y; Liu Y
J Pharmacol Sci; 2018 Jul; 137(3):305-312. PubMed ID: 30119963
[TBL] [Abstract][Full Text] [Related]
29. Chemoproteomics-enabled discovery of covalent RNF114-based degraders that mimic natural product function.
Luo M; Spradlin JN; Boike L; Tong B; Brittain SM; McKenna JM; Tallarico JA; Schirle M; Maimone TJ; Nomura DK
Cell Chem Biol; 2021 Apr; 28(4):559-566.e15. PubMed ID: 33513350
[TBL] [Abstract][Full Text] [Related]
30. Phytochemicals, withaferin A and carnosol, overcome pancreatic cancer stem cells as c-Met inhibitors.
Aliebrahimi S; Kouhsari SM; Arab SS; Shadboorestan A; Ostad SN
Biomed Pharmacother; 2018 Oct; 106():1527-1536. PubMed ID: 30119228
[TBL] [Abstract][Full Text] [Related]
31. Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation.
Chen KF; Yu HC; Liu TH; Lee SS; Chen PJ; Cheng AL
J Hepatol; 2010 Jan; 52(1):88-95. PubMed ID: 19913321
[TBL] [Abstract][Full Text] [Related]
32. Metabonomics applied in exploring the antitumour mechanism of physapubenolide on hepatocellular carcinoma cells by targeting glycolysis through the Akt-p53 pathway.
Ma T; Fan BY; Zhang C; Zhao HJ; Han C; Gao CY; Luo JG; Kong LY
Sci Rep; 2016 Jul; 6():29926. PubMed ID: 27416811
[TBL] [Abstract][Full Text] [Related]
33. Regiospecific Synthesis of Ring A Fused Withaferin A Isoxazoline Analogues: Induction of Premature Senescence by W-2b in Proliferating Cancer Cells.
Rasool F; Nayak D; Katoch A; Faheem MM; Yousuf SK; Hussain N; Belawal C; Satti NK; Goswami A; Mukherjee D
Sci Rep; 2017 Oct; 7(1):13749. PubMed ID: 29062040
[TBL] [Abstract][Full Text] [Related]
34. S-equol, a Secondary Metabolite of Natural Anticancer Isoflavone Daidzein, Inhibits Prostate Cancer Growth In Vitro and In Vivo, Though Activating the Akt/FOXO3a Pathway.
Lu Z; Zhou R; Kong Y; Wang J; Xia W; Guo J; Liu J; Sun H; Liu K; Yang J; Mi M; Xu H
Curr Cancer Drug Targets; 2016; 16(5):455-65. PubMed ID: 26638886
[TBL] [Abstract][Full Text] [Related]
35. Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation.
Qin JJ; Wang W; Voruganti S; Wang H; Zhang WD; Zhang R
Oncotarget; 2015 Feb; 6(5):2623-40. PubMed ID: 25739118
[TBL] [Abstract][Full Text] [Related]
36. Targeting protein phosphatase PP2A for cancer therapy: development of allosteric pharmaceutical agents.
Brautigan DL; Farrington C; Narla G
Clin Sci (Lond); 2021 Jul; 135(13):1545-1556. PubMed ID: 34192314
[TBL] [Abstract][Full Text] [Related]
37. Diverse Redoxome Reactivity Profiles of Carbon Nucleophiles.
Gupta V; Yang J; Liebler DC; Carroll KS
J Am Chem Soc; 2017 Apr; 139(15):5588-5595. PubMed ID: 28355876
[TBL] [Abstract][Full Text] [Related]
38.
Lee SO; Lee MH; Lee KR; Lee EO; Lee HJ
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845749
[No Abstract] [Full Text] [Related]
39. Chemoproteomics-Enabled Covalent Ligand Screening Reveals a Thioredoxin-Caspase 3 Interaction Disruptor That Impairs Breast Cancer Pathogenicity.
Anderson KE; To M; Olzmann JA; Nomura DK
ACS Chem Biol; 2017 Oct; 12(10):2522-2528. PubMed ID: 28892616
[TBL] [Abstract][Full Text] [Related]
40. The effect of a PP2A inhibitor on the nuclear receptor corepressor pathway in glioma.
Lu J; Zhuang Z; Song DK; Mehta GU; Ikejiri B; Mushlin H; Park DM; Lonser RR
J Neurosurg; 2010 Aug; 113(2):225-33. PubMed ID: 20001590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
